Why Madrigal Stock, Which Has Gained 62% In A Month, Just Slumped Ahead Of A Potential First-Ever In MASHInvestors Business Daily • 03/14/24
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.The Motley Fool • 03/09/24
1 Wall Street Analyst Thinks Madrigal Pharmaceuticals Stock Is Going to $347. Is It a Buy Around $247?The Motley Fool • 03/05/24
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 02/28/24
Madrigal Pharmaceuticals Presents Five Health Economics Outcomes Research Abstracts at the NASH-TAG Annual ConferenceGlobeNewsWire • 01/04/24
Madrigal Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/24
Madrigal Pharmaceuticals Appoints Ronald Filippo as Chief Information OfficerGlobeNewsWire • 11/21/23
Madrigal Pharmaceuticals Appoints Carole Huntsman as Chief Commercial OfficerGlobeNewsWire • 11/10/23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial ResultsGlobeNewsWire • 11/06/23
Madrigal Pharmaceuticals Bolstered By $500 Million Equity Infusion Is A 'Buy' Into 2024Seeking Alpha • 11/05/23